CoChat

Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Ischemic preconditioning (IPC) affords tissue protection in organs including kidneys; however, the underlying mechanism remains unclear. Here we demonstrate an important role of macroautophagy/autophagy (especially mitophagy) in the protective effect of IPC in kidneys. IPC induced autophagy in renal tubular cells in mice and suppressed subsequent renal ischemia-reperfusion injury (IRI). The protective effect of IPC was abolished by pharmacological inhibitors of autophagy and by the ablation of Atg7 from kidney proximal tubules. Pretreatment with BECN1/Beclin1 peptide induced autophagy and protected against IRI. These results suggest the dependence of IPC protection on renal autophagy. During IPC, the mitophagy regulator PINK1 (PTEN induced putative kinase 1) was activated. Both IPC and BECN1 peptide enhanced mitolysosome formation during renal IRI in mitophagy reporter mice, suggesting that IPC may protect kidneys by activating mitophagy. We further established an in vitro model of IPC by inducing ‘chemical ischemia’ in kidney proximal tubular cells with carbonyl cyanide 3-chlorophenylhydrazone (CCCP). Brief treatment with CCCP protected against subsequent injury in these cells and the protective effect was abrogated by autophagy inhibition. In vitro IPC increased mitophagosome formation, enhanced the delivery of mitophagosomes to lysosomes, and promoted the clearance of damaged mitochondria during subsequent CCCP treatment. IPC also suppressed mitochondrial depolarization, improved ATP production, and inhibited the generation of reactive oxygen species. Knockdown of Pink1 suppressed mitophagy and reduced the cytoprotective effect of IPC. Together, these results suggest that autophagy, especially mitophagy, plays an important role in the protective effect of IPC.Abbreviations: ACTB: actin, beta; ATG: autophagy related; BNIP3: BCL2 interacting protein 3; BNIP3L/NIX: BCL2 interacting protein 3 like; BUN: blood urea nitrogen; CASP3: caspase 3; CCCP: carbonyl cyanide 3-chlorophenylhydrazone; COX4I1: cytochrome c oxidase subunit 4I1; COX8: cytochrome c oxidase subunit 8; DAPI: 4ʹ,6-diamidino-2-phenylindole; DNM1L: dynamin 1 like; EGFP: enhanced green fluorescent protein; EM: electron microscopy; ER: endoplasmic reticulum; FC: floxed control; FIS1: fission, mitochondrial 1; FUNDC1: FUN14 domain containing 1; H-E: hematoxylin-eosin; HIF1A: hypoxia inducible factor 1 subunit alpha; HSPD1: heat shock protein family D (Hsp60) member 1; IMMT/MIC60: inner membrane mitochondrial protein; IPC: ischemic preconditioning; I-R: ischemia-reperfusion; IRI: ischemia-reperfusion injury; JC-1: 5,5ʹ,6,6ʹ-tetrachloro-1,1ʹ,3,3ʹ-tetraethylbenzimidazolylcarbocyanine iodide; KO: knockout; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; mito-QC: mito-quality control; mRFP: monomeric red fluorescent protein; NAC: N-acetylcysteine; PINK1: PTEN induced putative kinase 1; PPIB: peptidylprolyl isomerase B; PRKN: parkin RBR E3 ubiquitin protein ligase; ROS: reactive oxygen species; RPTC: rat proximal tubular cells; SD: standard deviation; sIPC: simulated IPC; SQSTM1/p62: sequestosome 1; TOMM20: translocase of outer mitochondrial membrane 20; TUNEL: terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15548627.2019.1615822

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Renal IPC protects against renal IRI in C57BL/6 mice. Mice were subjected to 15-min bilateral renal ischemia followed by 1 h of reperfusion to induce renal IPC. To induce renal IRI, mice were subsequently treated with 27-min bilateral renal ischemia followed by 24 to 48 h of reperfusion (I-R) (sham: n = 3; I-R: n = 7; IPC + I-R: n = 10). Blood and kidneys were collected at the indicated time points for renal function, histology and immunoblot analyses. (a) BUN. (b) Serum creatinine. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group. (c) Representative histology of renal cortex and outer medulla H-E staining. Scale bar: 50 µm. (d) Pathological score of tubular damage. (e) Representative images of TUNEL staining. Scale bar: 50 µm. (f) Quantification of TUNEL-positive cells. Data in (d and f) are expressed as mean ± SD. *, P < 0.05, significantly different from I-R group. (g) Representative blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of the sham sample was arbitrarily set as 1, and the signals of other conditions were normalized to the sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group.
Figure 1. Renal IPC protects against renal IRI in C57BL/6 mice. Mice were subjected to 15-min bilateral renal ischemia followed by 1 h of reperfusion to induce renal IPC. To induce renal IRI, mice were subsequently treated with 27-min bilateral renal ischemia followed by 24 to 48 h of reperfusion (I-R) (sham: n = 3; I-R: n = 7; IPC + I-R: n = 10). Blood and kidneys were collected at the indicated time points for renal function, histology and immunoblot analyses. (a) BUN. (b) Serum creatinine. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group. (c) Representative histology of renal cortex and outer medulla H-E staining. Scale bar: 50 µm. (d) Pathological score of tubular damage. (e) Representative images of TUNEL staining. Scale bar: 50 µm. (f) Quantification of TUNEL-positive cells. Data in (d and f) are expressed as mean ± SD. *, P < 0.05, significantly different from I-R group. (g) Representative blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of the sham sample was arbitrarily set as 1, and the signals of other conditions were normalized to the sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group.CC BY · PubMed Central
Figure 2. Induction of autophagy in proximal tubules during renal IPC. C57BL/6 (a–e) and CAGp-RFP-GFP-LC3 (f–h) mice were subjected to renal IPC only without subsequent renal IRI (C57BL/6 mice: sham: n = 3; IPC: n = 6; CAGp-RFP-GFP-LC3 mice: n = 3 for each). Kidneys were collected after preconditioning for histological and immunoblot analyses. (a) Representative blots of LC3B and SQSTM1. ACTB was used as a loading control. (b) Densitometric analysis of LC3B-II and SQSTM1. After normalization with ACTB, the protein signals of the sham were arbitrarily set as 1, and the signals of other conditions were normalized to the sham to calculate fold changes. (c) Representative images of immunohistochemical staining of LC3B. Scale bar: 20 µm. (d) Quantitative analysis of punctate LC3B staining. Data in (b and d) are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group. (e) Representative electron micrographs showing autophagic vacuoles (arrows) (n = 2 for each). Scale bar: 2 µm (3 upper panels) and 200 nm (6 lower panels). (f) Representative images of GFP-LC3 and RFP-LC3 fluorescence staining. Scale bar: 15 µm. (g) Quantitative analysis of yellow and red LC3 puncta. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, values of red LC3 puncta significantly different from the relevant values of yellow LC3 puncta. (h) Analysis of autophagic flux rate. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group.
Figure 2. Induction of autophagy in proximal tubules during renal IPC. C57BL/6 (a–e) and CAGp-RFP-GFP-LC3 (f–h) mice were subjected to renal IPC only without subsequent renal IRI (C57BL/6 mice: sham: n = 3; IPC: n = 6; CAGp-RFP-GFP-LC3 mice: n = 3 for each). Kidneys were collected after preconditioning for histological and immunoblot analyses. (a) Representative blots of LC3B and SQSTM1. ACTB was used as a loading control. (b) Densitometric analysis of LC3B-II and SQSTM1. After normalization with ACTB, the protein signals of the sham were arbitrarily set as 1, and the signals of other conditions were normalized to the sham to calculate fold changes. (c) Representative images of immunohistochemical staining of LC3B. Scale bar: 20 µm. (d) Quantitative analysis of punctate LC3B staining. Data in (b and d) are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group. (e) Representative electron micrographs showing autophagic vacuoles (arrows) (n = 2 for each). Scale bar: 2 µm (3 upper panels) and 200 nm (6 lower panels). (f) Representative images of GFP-LC3 and RFP-LC3 fluorescence staining. Scale bar: 15 µm. (g) Quantitative analysis of yellow and red LC3 puncta. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, values of red LC3 puncta significantly different from the relevant values of yellow LC3 puncta. (h) Analysis of autophagic flux rate. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group.CC BY · PubMed Central
Figure 3. The protective effects of IPC against renal IRI are abrogated in PT-atg7 KO mice. (a) Floxed control (PT-Atg7 FC) and PT-atg7 KO mice were treated with sham or IPC and kidneys were collected for immunoblot analysis of LC3B and SQSTM1 (n = 3 for each). ACTB was used as a loading control. Floxed control and PT-atg7 KO mice were subjected to: (1) sham (n = 3 for each); (2) I-R (n = 8 for FC; n = 9 for KO); (3) IPC + I-R (n = 10 for each). Blood and kidneys were collected at the indicated time points for renal function, histology and immunoblot analyses. (b) BUN. (c) Serum creatinine. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group. (d) Representative histology of renal cortex and outer medulla H-E staining. Scale bar: 50 µm. (e) Pathological score of tubular damage. (f) Representative images of TUNEL staining. Scale bar: 50 µm. (g) Quantification of TUNEL-positive cells. Data in (e and g) are expressed as mean ± SD. *, P < 0.05, significantly different from I-R group. (h) Representative blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of the sham was arbitrarily set as 1, and the signals of other conditions were normalized to the sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group.
Figure 3. The protective effects of IPC against renal IRI are abrogated in PT-atg7 KO mice. (a) Floxed control (PT-Atg7 FC) and PT-atg7 KO mice were treated with sham or IPC and kidneys were collected for immunoblot analysis of LC3B and SQSTM1 (n = 3 for each). ACTB was used as a loading control. Floxed control and PT-atg7 KO mice were subjected to: (1) sham (n = 3 for each); (2) I-R (n = 8 for FC; n = 9 for KO); (3) IPC + I-R (n = 10 for each). Blood and kidneys were collected at the indicated time points for renal function, histology and immunoblot analyses. (b) BUN. (c) Serum creatinine. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group. (d) Representative histology of renal cortex and outer medulla H-E staining. Scale bar: 50 µm. (e) Pathological score of tubular damage. (f) Representative images of TUNEL staining. Scale bar: 50 µm. (g) Quantification of TUNEL-positive cells. Data in (e and g) are expressed as mean ± SD. *, P < 0.05, significantly different from I-R group. (h) Representative blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of the sham was arbitrarily set as 1, and the signals of other conditions were normalized to the sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group.CC BY · PubMed Central
Figure 4. Pharmacological preconditioning with Tat-BECN1 protects against renal IRI in C57BL/6 mice. C57BL/6 mice were pretreated with Tat-BECN1 and its control peptide (Tat-Scramble) at a single dose of 20 mg/kg i.p. injection. Four h after preconditioning, mice were subjected to 27-min bilateral renal ischemia followed by 24 to 48 h of reperfusion (sham: n = 3 for each; Tat-Scramble + I-R: n = 8; Tat-BECN1 + I-R: n = 10). Blood and kidneys were collected at the indicated time points for renal function, histology and immunoblot analyses. (a and b) BUN and serum creatinine. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from Tat-Scramble + I-R group. (c) Representative histology of renal cortex and outer medulla H-E staining. Scale bar: 50 µm. (d) Pathological score of tubular damage. (e) Representative images of TUNEL staining. Scale bar: 50 µm. (f) Quantification of TUNEL-positive cells. Data in (d and f) are expressed as mean ± SD. *, P < 0.05, significantly different from Tat-Scramble + I-R group. (g) Representative blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of Tat-Scramble + sham was arbitrarily set as 1, and the signals of other conditions were normalized to the Tat-Scramble + sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from Tat-Scramble + I-R group.
Figure 4. Pharmacological preconditioning with Tat-BECN1 protects against renal IRI in C57BL/6 mice. C57BL/6 mice were pretreated with Tat-BECN1 and its control peptide (Tat-Scramble) at a single dose of 20 mg/kg i.p. injection. Four h after preconditioning, mice were subjected to 27-min bilateral renal ischemia followed by 24 to 48 h of reperfusion (sham: n = 3 for each; Tat-Scramble + I-R: n = 8; Tat-BECN1 + I-R: n = 10). Blood and kidneys were collected at the indicated time points for renal function, histology and immunoblot analyses. (a and b) BUN and serum creatinine. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from Tat-Scramble + I-R group. (c) Representative histology of renal cortex and outer medulla H-E staining. Scale bar: 50 µm. (d) Pathological score of tubular damage. (e) Representative images of TUNEL staining. Scale bar: 50 µm. (f) Quantification of TUNEL-positive cells. Data in (d and f) are expressed as mean ± SD. *, P < 0.05, significantly different from Tat-Scramble + I-R group. (g) Representative blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of Tat-Scramble + sham was arbitrarily set as 1, and the signals of other conditions were normalized to the Tat-Scramble + sham to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from Tat-Scramble + I-R group.CC BY · PubMed Central
Figure 5. Both renal IPC and Tat-BECN1 preconditioning enhance mitophagy in proximal tubules during subsequent renal IRI in mice. (a) C57BL/6 mice were subjected to: (1) sham (n = 3); (2) I-R (n = 7); (3) IPC + I-R (n = 10). Kidneys were collected for immunoblot analysis of PINK1, COX4I1, IMMT/MIC60, and TOMM20. PPIB (peptidylprolyl isomerase B) was used as a loading control. Mito-QC mice were subjected to: (1) sham (n = 3); (2) IPC (n = 3); (3) I-R (n = 4); (4) IPC + I-R (n = 5). Kidneys were collected to determine mitophagy flux by fluorescence microscopy. (b) Representative images of the formation of mitolysosomes. Scale bar: 20 µm for low magnification and 5 µm for high magnification. (c) Quantitative analysis of the number of mitolysosomes per 400× field (renal cortex and outer stripe of outer medulla, glomeruli excluded). Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group. Furthermore, mito-QC mice were pretreated with Tat-BECN1 and its control peptide (Tat-Scramble) at a single dose of 20 mg/kg i.p. injection. Four h after preconditioning, mice were subjected to sham surgery or 27-min bilateral renal ischemia followed by 48 h of reperfusion (n = 3 for each). Kidneys were collected to determine mitophagy flux by fluorescence microscopy. (d) Representative images of the formation of mitolysosomes. Scale bar: 20 µm. (e) Quantitative analysis of the number of mitolysosomes per 400× field (renal cortex and outer stripe of outer medulla, glomeruli excluded). Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from Tat-Scramble + I-R group.
Figure 5. Both renal IPC and Tat-BECN1 preconditioning enhance mitophagy in proximal tubules during subsequent renal IRI in mice. (a) C57BL/6 mice were subjected to: (1) sham (n = 3); (2) I-R (n = 7); (3) IPC + I-R (n = 10). Kidneys were collected for immunoblot analysis of PINK1, COX4I1, IMMT/MIC60, and TOMM20. PPIB (peptidylprolyl isomerase B) was used as a loading control. Mito-QC mice were subjected to: (1) sham (n = 3); (2) IPC (n = 3); (3) I-R (n = 4); (4) IPC + I-R (n = 5). Kidneys were collected to determine mitophagy flux by fluorescence microscopy. (b) Representative images of the formation of mitolysosomes. Scale bar: 20 µm for low magnification and 5 µm for high magnification. (c) Quantitative analysis of the number of mitolysosomes per 400× field (renal cortex and outer stripe of outer medulla, glomeruli excluded). Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from I-R group. Furthermore, mito-QC mice were pretreated with Tat-BECN1 and its control peptide (Tat-Scramble) at a single dose of 20 mg/kg i.p. injection. Four h after preconditioning, mice were subjected to sham surgery or 27-min bilateral renal ischemia followed by 48 h of reperfusion (n = 3 for each). Kidneys were collected to determine mitophagy flux by fluorescence microscopy. (d) Representative images of the formation of mitolysosomes. Scale bar: 20 µm. (e) Quantitative analysis of the number of mitolysosomes per 400× field (renal cortex and outer stripe of outer medulla, glomeruli excluded). Data are expressed as mean ± SD. *, P < 0.05, significantly different from the sham group; #, P < 0.05, significantly different from Tat-Scramble + I-R group.CC BY · PubMed Central
Figure 6. In vitro sIPC attenuates prolonged CCCP-induced apoptosis in RPTC cells. In vitro sIPC was induced by incubating RPTC cells with 20 μM CCCP for 30 min followed by 40 min of recovery. The cells were then treated with prolonged CCCP (20 μM) for 3 h followed by 2 h of recovery to model in vivo renal IRI. Cells were collected for analysis of apoptosis by morphology and caspase activation. (a) Representative images of phase contrast and fluorescence microscopy showing cellular and nuclear morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. (c) Representative blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of the control was arbitrarily set as 1, and the signals of other conditions were normalized to the control to calculate fold changes. Data in (b and c) are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group.
Figure 6. In vitro sIPC attenuates prolonged CCCP-induced apoptosis in RPTC cells. In vitro sIPC was induced by incubating RPTC cells with 20 μM CCCP for 30 min followed by 40 min of recovery. The cells were then treated with prolonged CCCP (20 μM) for 3 h followed by 2 h of recovery to model in vivo renal IRI. Cells were collected for analysis of apoptosis by morphology and caspase activation. (a) Representative images of phase contrast and fluorescence microscopy showing cellular and nuclear morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. (c) Representative blots and densitometric analysis of cleaved CASP3. ACTB was used as a loading control. After normalization with ACTB, the protein signal of the control was arbitrarily set as 1, and the signals of other conditions were normalized to the control to calculate fold changes. Data in (b and c) are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group.CC BY · PubMed Central
Figure 7. The cytoprotection of in vitro sIPC is diminished by autophagy inhibitors in RPTC cells. RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R in the absence or presence of chloroquine (20 μM) and 3-methyladenine (10 mM). Both inhibitors were used for 1-h pretreatment and during 2-h recovery from prolonged CCCP treatment. Cells were collected for morphological and immunoblot analyses. (a) Representative images of phase contrast and fluorescence microscopy showing cellular and nuclear morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group. (c) Analysis of apoptosis inhibitory efficiency by sIPC. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the group without inhibitors. (d and e) Immunoblots of LC3B and cleaved CASP3. ACTB was used as a loading control. The molecular mass marker lanes were labelled as kDa. For densitometric analysis of cleaved CASP3, after normalization with ACTB, the protein signals of the control were arbitrarily set as 1, and the signals of other conditions were normalized to the control to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group.
Figure 7. The cytoprotection of in vitro sIPC is diminished by autophagy inhibitors in RPTC cells. RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R in the absence or presence of chloroquine (20 μM) and 3-methyladenine (10 mM). Both inhibitors were used for 1-h pretreatment and during 2-h recovery from prolonged CCCP treatment. Cells were collected for morphological and immunoblot analyses. (a) Representative images of phase contrast and fluorescence microscopy showing cellular and nuclear morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group. (c) Analysis of apoptosis inhibitory efficiency by sIPC. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the group without inhibitors. (d and e) Immunoblots of LC3B and cleaved CASP3. ACTB was used as a loading control. The molecular mass marker lanes were labelled as kDa. For densitometric analysis of cleaved CASP3, after normalization with ACTB, the protein signals of the control were arbitrarily set as 1, and the signals of other conditions were normalized to the control to calculate fold changes. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group.CC BY · PubMed Central
Figure 8. In vitro sIPC suppresses mitochondrial depolarization, improves ATP production and reduces ROS generation in prolonged CCCP-treated RPTC cells. RPTC cells were incubated with 1 μg/ml JC-1 for 1 h and then treated with: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. Live cells were collected 1 h after reperfusion for fluorescence microscopy. (a) Representative images of JC-1 staining showing red fluorescence of JC-1 aggregate and green signal of monomer. Scale bar: 50 μm. (b) Quantification of the ratio of green to red fluorescence. (c) RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. Thirty min after reperfusion cells were collected for quantitative determination of ATP by a luciferin-luciferase luminescence assay. Data in (b and c) are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group. (d) RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R; (4) CQ + sIPC + CCCP-R; (5) NAC + CCCP-R. After treatment cells were incubated with 5 μM CellROX Deep Red reagent for 30 min. ROS generation was visualized by fluorescence microscopy. Scale bar: 50 μm.
Figure 8. In vitro sIPC suppresses mitochondrial depolarization, improves ATP production and reduces ROS generation in prolonged CCCP-treated RPTC cells. RPTC cells were incubated with 1 μg/ml JC-1 for 1 h and then treated with: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. Live cells were collected 1 h after reperfusion for fluorescence microscopy. (a) Representative images of JC-1 staining showing red fluorescence of JC-1 aggregate and green signal of monomer. Scale bar: 50 μm. (b) Quantification of the ratio of green to red fluorescence. (c) RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. Thirty min after reperfusion cells were collected for quantitative determination of ATP by a luciferin-luciferase luminescence assay. Data in (b and c) are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group. (d) RPTC cells were subjected to: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R; (4) CQ + sIPC + CCCP-R; (5) NAC + CCCP-R. After treatment cells were incubated with 5 μM CellROX Deep Red reagent for 30 min. ROS generation was visualized by fluorescence microscopy. Scale bar: 50 μm.CC BY · PubMed Central
Figure 9. Knockdown of Pink1 inhibits mitophagy flux in CCCP-treated RPTC cells. (a) RPTC cells were subjected to: (1) control; (2) sIPC; (3) CCCP-R; (4) sIPC + CCCP-R. After treatment mitochondrial fractions were collected for immunoblot analysis of multiple mitophagy-related proteins including PINK1, PRKN, BNIP3L/NIX, FUNDC1 and DNM1L. HSPD1, a mitochondrial matrix protein, was used as a loading control. (b) RPTC cells were infected with retroviral Pink1 shRNA constructs (A–D) and a negative control (NC) construct. Upon puromycin selection, stable cells were collected for immunoblot analysis of PINK1. PPIB was used as a loading control. Based on the inhibitory effects, the stable cells (negative control, Pink1 shRNA A, Pink1 shRNA C) were transfected with COX8-EGFP-mCherry and then treated with: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. Cells were collected for fluorescence microscopy. (c) Representative images of mitolysosome formation. Scale bar: 10 μm. (d) Quantitative analysis of the number of mitolysosomes per cell. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group; ^, P < 0.05, significantly different from the corresponding groups in negative control cells.
Figure 9. Knockdown of Pink1 inhibits mitophagy flux in CCCP-treated RPTC cells. (a) RPTC cells were subjected to: (1) control; (2) sIPC; (3) CCCP-R; (4) sIPC + CCCP-R. After treatment mitochondrial fractions were collected for immunoblot analysis of multiple mitophagy-related proteins including PINK1, PRKN, BNIP3L/NIX, FUNDC1 and DNM1L. HSPD1, a mitochondrial matrix protein, was used as a loading control. (b) RPTC cells were infected with retroviral Pink1 shRNA constructs (A–D) and a negative control (NC) construct. Upon puromycin selection, stable cells were collected for immunoblot analysis of PINK1. PPIB was used as a loading control. Based on the inhibitory effects, the stable cells (negative control, Pink1 shRNA A, Pink1 shRNA C) were transfected with COX8-EGFP-mCherry and then treated with: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. Cells were collected for fluorescence microscopy. (c) Representative images of mitolysosome formation. Scale bar: 10 μm. (d) Quantitative analysis of the number of mitolysosomes per cell. Data are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group; ^, P < 0.05, significantly different from the corresponding groups in negative control cells.CC BY · PubMed Central
Figure 10. In vitro sIPC-mediated cytoprotection is compromised by Pink1 knockdown in RPTC cells. RPTC stable cell lines (negative control, Pink1 shRNA A, Pink1 shRNA C) were established as described in Figure 9. The cells were then treated with: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. After treatment cells were collected for morphological, biochemical and immunoblot analyses. (a) Representative images of phase contrast and fluorescence microscopy showing cellular and nuclear morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. (c) Representative images of cleaved CASP3 immunoblot. ACTB was used as a loading control. The molecular mass marker lane was labelled as kDa. (d) Densitometric analysis of cleaved CASP3 immunoblots. After normalization with ACTB, the protein signals of the control in negative control cells were arbitrarily set as 1, and the signals of other conditions were normalized to calculate fold changes. (e) Quantitative analysis of JC-1 staining (the ratio of green to red fluorescence). Cells were loaded with 1 μg/ml JC-1 for 1 h prior to CCCP treatment. Live cells were collected for fluorescence microscopy. (f) Bioluminescence assay of ATP production. Data in (b,d–f) are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group.
Figure 10. In vitro sIPC-mediated cytoprotection is compromised by Pink1 knockdown in RPTC cells. RPTC stable cell lines (negative control, Pink1 shRNA A, Pink1 shRNA C) were established as described in Figure 9. The cells were then treated with: (1) control; (2) CCCP-R; (3) sIPC + CCCP-R. After treatment cells were collected for morphological, biochemical and immunoblot analyses. (a) Representative images of phase contrast and fluorescence microscopy showing cellular and nuclear morphology of apoptosis. Scale bar: 200 μm. (b) Quantification of cell apoptosis. (c) Representative images of cleaved CASP3 immunoblot. ACTB was used as a loading control. The molecular mass marker lane was labelled as kDa. (d) Densitometric analysis of cleaved CASP3 immunoblots. After normalization with ACTB, the protein signals of the control in negative control cells were arbitrarily set as 1, and the signals of other conditions were normalized to calculate fold changes. (e) Quantitative analysis of JC-1 staining (the ratio of green to red fluorescence). Cells were loaded with 1 μg/ml JC-1 for 1 h prior to CCCP treatment. Live cells were collected for fluorescence microscopy. (f) Bioluminescence assay of ATP production. Data in (b,d–f) are expressed as mean ± SD. *, P < 0.05, significantly different from the control group; #, P < 0.05, significantly different from CCCP-R group.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 50 references

Cited by

See all 254

Metadata

Authors
Livingston, M. J., Wang, J., Zhou, J., Wu, G., Ganley, I. G., Hill, J. A., Yin, X.-M., & Dong, Z.
Affiliations
  • Augusta University (US)
  • Central South University (CN)
  • University of Dundee (GB)
  • The University of Texas Southwestern Medical Center (US)
  • Indiana University School of Medicine (US)
Corresponding author
Dong, Zheng
Venue
Autophagy
Published
2019-05-22
Volume
15
Issue
12
Pages
2142-2162
ISSN
  • 1554-8627 (ISSN-L)
  • 1554-8635
OpenAlex
W2944644737
Cited by
254
References
50
Citations by year
2026: 24 · 2025: 29 · 2024: 48 · 2023: 39 · 2022: 49 · 2021: 34 · 2020: 28 · 2019: 3
FWCI
21.69
Type
journal article
Language
en
Open access
Locations
  • Autophagy (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion, cc-by-nc-nd)
  • IUScholarWorks (Indiana University) (submittedVersion)
Funders
  • Medical Research Council (00018/2)
  • National Institutes of Health (58831, 87843)
  • U.S. Department of Veterans Affairs (319)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
ischemic preconditioning, mitophagy, renal ischemia-reperfusion injury, renal protection, PINK1, Beclin-1, ATG7, mitochondrial depolarization, reactive oxygen species, proximal tubular epithelial cells, chemical ischemia, carbonyl cyanide 3-chlorophenylhydrazone, ATP production
MeSH terms
Autophagosomes, Beclin-1, Autophagy-Related Protein 7, PTEN-Induced Putative Kinase, Animals, Carbonyl Cyanide m-Chlorophenyl Hydrazone, Cell Line, Kidney, Kidney Tubules, Proximal, Lysosomes, Male, Mice, Inbred C57BL, Mice, Transgenic, Mitochondria, Protein Kinases, Reperfusion Injury, Apoptosis, Reactive Oxygen Species, Ischemic Preconditioning, Apoptosis Regulatory Proteins, Mitochondrial Membranes, Mice, Rats, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys. https://app.cochat.ai/papers/10.1080/15548627.2019.1615822
The paper
Livingston, M. J., Wang, J., Zhou, J., Wu, G., Ganley, I. G., Hill, J. A., Yin, X.-M., & Dong, Z. (2019). Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys. Autophagy. https://doi.org/10.1080/15548627.2019.1615822

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.